Skip to playerSkip to main content
  • 2 years ago
A vaccine for the respiratory virus RSV will soon be available for people aged 60 and above. The therapeutic goods administration has approved the use of the vaccine for people with a prescription, to help stop the potentially deadly virus in its tracks. Most cases of the virus are mild, but some can lead to chest infections like bronchiolitis and pneumonia.

Category

đŸ“º
TV
Transcript
00:00 RSV is one of the three big respiratory viruses.
00:05 So we have the COVID-19, we have influenza,
00:09 and we now have RSV.
00:11 And RSV was only made notifiable in 2021.
00:15 So we're still getting a real handle on
00:18 how bad it can become.
00:19 But last year, for example,
00:21 there were 130,000 notified cases.
00:24 So it is quite a substantial disease.
00:26 There are two types of vaccines
00:28 which have been approved in the USA.
00:30 One is for pregnant women,
00:32 and that protects young children up to six months of age.
00:36 And the other is for older people 60 years and above.
00:38 And it's that second one that's now available in Australia.
00:41 So yes, it can be of great help to people
00:44 who are at high risk in the older age groups,
00:47 but we're still waiting approval for the vaccine
00:49 for pregnant women in Australia.
00:51 [BLANK_AUDIO]
Comments

Recommended